Item | Observation (n = 265) | Control (n = 163) | P |
---|---|---|---|
Age | 62.0 ± 9.3 | 61.3 ± 9.0 | 0.247 |
Male | 123 (46.4) | 76 (46.6) | 0.996 |
BMI | 22.2 ± 2.0 | 21.8 ± 2.6 | 0.086 |
Tumor types | |||
Gastrointestinal cancer | 105 (39.6) | 61 (37.4) | 0.650 |
Lung cancer | 47 (17.7) | 37 (22.7) | 0.209 |
Breast cancer | 56 (21.1) | 32 (19.6) | 0.709 |
Gynecologic cancer | 25 (9.4) | 16 (9.8) | 0.896 |
Malignant lymphoma | 10 (3.8) | 6 (3.7) | 0.961 |
Other tumors | 22 (8.3) | 11 (6.7) | 0.559 |
Surgery | 182 (68.7) | 116 (71.2) | 0.587 |
ALT before chemotherapy | 26.2 ± 7.8 | 25.4 ± 9.4 | 0.361 |
TC before chemotherapy | 5.5 ± 1.2 | 4.7 ± 0.7 | 0.000 |
TG before chemotherapy | 1.8 ± 0.6 | 1.3 ± 0.2 | 0.000 |
HDL before chemotherapy | 1.3 ± 0.5 | 1.4 ± 0.4 | 0.000 |
LDL before chemotherapy | 3.2 ± 1.1 | 2.9 ± 0.8 | 0.010 |